Wang S#, Tao C#, Mao H, Hou L, Wang Y, Qi T, Yang Y, Ong SG, Hu S*, Chai R*, Wang Y*. Identification of SaCas9 orthologs containing a conserved serine residue that determines simple NNGG PAM recognition. PLoS Biol. 2022 Nov 30;20(11):e3001897.

Xiao Y#, Chen Y#, Shao C#, Wang Y, Hu S*, Lei W*. Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction. Front Bioeng Biotechnol. 2022 Aug 5;10:973496.

Li C, Feng Y, Fu Z, Deng J, Gu Y, Wang H, Wu X, Huang Z, Zhu Y, Liu Z, Huang M, Wang T, Hu S, Yao B, Zeng Y, Zhou CJ, Brown SDM, Liu Y, Vidal-Puig A, Dong Y, Xu Y. Human-specific gene CT47 blocks PRMT5 degradation to lead to meiosis arrest. Cell Death Discov. 2022 Aug 2;8(1):345.

Wang Y#, Yu M#, Hao K#, Lei W, Tang M*, Hu S*. Cardiomyocyte Maturation-the Road is not Obstructed. Stem Cell Rev Rep. 2022 Dec;18(8):2966-2981.

Yang Z#, Yu M#, Li X#, Tu Y#, Wang C#, Lei W, Song M, Wang Y, Huang Y, Ding F, Hao K, Han X, Ni X, Qu L*, Shen Z*, Hu S*. Retinoic acid inhibits the angiogenesis of human embryonic stem cell-derived endothelial cells by activating FBP1-mediated gluconeogenesis. Stem Cell Res Ther. 2022 Jun 7;13(1):239.

Yu M, Lan F, Zhao MT, Ye L, Hu S*. Editorial: Stem Cells and Cardiovascular Diseases. Front Cell Dev Biol. 2022 Feb 28;10:862482.

Zhang Y#, Wei J#, Cao J#, Zhang K#, Peng Y, Deng H, Kang J, Pan G, Zhang Y, Fu B, Hu S, Na J, Liu Y, Wang L, Liang L, Zhu H, Zhang Y, Jin ZB, Hao J*, Ma A*, Zhao T*, Yu J*. Requirements for human-induced pluripotent stem cells. Cell Prolif. 2022 Apr;55(4):e13182.

Chen X#, Huang J#, Wu J#, Hao J#, Fu B, Wang Y, Zhou B, Na T, Wei J, Zhang Y, Li Q, Hu S, Zhou J, Yu J, Wu Z, Zhu H, Cao J, Wang L, Peng Y, Liang L, Ma A*, Zhang Y*, Zhao T*, Xiang AP*. Human mesenchymal stem cells. Cell Prolif. 2022 Apr;55(4):e13141.

Nan X#, Zhang B#, Hao J#, Yue W#, Fu B, Qu M, Zhang Y, Wang H, Fang F, Wei J, Li Q, Hu S, Yu J, Gao Y, Liu Q, Cao J, Wang L, Peng Y, Zhu H, Liang L, Ma A*, Zhou J*, Zhao T*, Pei X*. Requirements for human haematopoietic stem/progenitor cells. Cell Prolif. 2022 Apr;55(4):e13152.

Peng Z#, Wu J#, Hu S#, Ma A#, Wang L, Cao N, Zhang Y, Li Q, Yu J, Meng S, Na T, Shi X, Li M, Liu H, Qian L, Tian E, Lin F, Cao J, Peng Y, Zhu H, Liang L, Hao J*, Zhao T*, Cheng X*, Pan G*. Requirments for primary human hepatocyte. Cell Prolif. 2022 Apr;55(4):e13147.

Wang L#, Cao J#, Peng Y#, Fu B#, Jin Z, Hu Y, Wu W, Xiang AP, Hu S, Yu J, Zhang Y, Wei J, Zhang Y, Li Q, Zhou J, Zhai P, Zhu H, Liang L, Ma A*, Stacey G*, Zhao T*, Hao J*. Human retinal pigment epithelial cells. Cell Prolif. 2022 Apr;55(4):e13153.

Yu M#, Lei W#, Cao J#, Wang L#, Ma A, Zhao ZA, Yang HT, Shen Z, Lan F, Cao F, Liang P, Pei X, Xiang AP, Yu J, Zhang Y, Zhang Y, Li Q, Zhou J, Wei J, Peng Y, Zhu H, Liang L, Cao N, Fu B*, Hao J*, Zhao T*, Hu S*. Requirements for human cardiomyocytes. Cell Prolif. 2022 Apr;55(4):e13150.

Ye L#, Yu Y#, Zhao ZA#, Zhao D, Ni X, Wang Y, Fang X, Yu M, Wang Y, Tang JM, Chen Y, Shen Z, Lei W, Hu S*. Patient-specific iPSC-derived cardiomyocytes reveal abnormal regulation of FGF16 in a familial atrial septal defect. Cardiovasc Res. 2022 Feb 21;118(3):859-871.

Ni X, Yang Z, Ye L, Han X, Zhao D, Ding F, Ding N, Wu H, Yu M, Xu GY, Zhao ZA, Lei W, Hu S*. Establishment of an in vitro safety assessment model for lipid-lowering drugs using same-origin human pluripotent stem cell-derived cardiomyocytes and endothelial cells. Acta Pharmacol Sin. 2022 Jan;43(1):240-250.

Wang S, Mao H, Hou L, Hu Z, Wang Y, Qi T, Tao C, Yang Y, Zhang C, Li M, Liu H, Hu S, Chai R*, Wang Y*. Compact SchCas9 Recognizes the Simple NNGR PAM. Adv Sci (Weinh). 2022 Feb;9(4):e2104789.